Jamincare

Jemincare is a leading Chinese pharmaceutical group headquartered in Nanchang, with a significant global R&D presence in Shanghai and the United States. The company operates across the entire value chain, including research, development, manufacturing, and commercialization of both traditional Chinese medicines and innovative small molecules and biologics. Jemincare's R&D pipeline is particularly strong in oncology, nephrology, and cardiovascular diseases, featuring advanced modalities such as PROTACs and antibody-drug conjugates. The company has gained international recognition through high-profile out-licensing deals with global partners like Genentech and Orion Corporation. With over 10,000 employees and multiple manufacturing bases, Jemincare is one of the largest private healthcare enterprises in China.